Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
C-Beyond Health was a private cannabinoid-focused healthcare product development company based in Golden, Colorado, with registered operations in Bangkok, Thailand. The company described itself as a patient-directed developer of targeted cannabinoid formulations and positioned its business around direct-to-consumer medicinal cannabis products. Its model combined cultivation, extraction, formulation, manufacturing, sales, marketing, and distribution, which it described as a vertically integrated "seed-to-body" platform. Public materials indicate planned products included sublingual sprays and topical salves developed with formulation partners. Available sources now indicate that C-Beyond Health Inc., also known as Medimorphic, is permanently closed.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on C-Beyond Health.